Psychological aspects and psychotherapy of inflammatory bowel diseases and irritable bowel syndrome in children

Biomedical Papers

Volumn 154, Issue 4, 2010, Pages 307-314

  Prasko, Jan ^a   Jelenova, Daniela ^a   Mihal, Vladimir ^a  

^a PALACKÝ UNIVERSITY   (Czech Republic)

Author keywords

Cognitive behavioral therapy; Crohn's disease; Inflammatory bowel disease; Irritable bowel syndrome; Psychological problems; Quality of life; Ulcerative colitis

Indexed keywords

EID: 78650804491     PISSN: 12138118     EISSN: 12138118     Source Type: Journal    
DOI: 10.5507/bp.2010.046     Document Type: Article

References (83)

1. Drossman DA, Li Z, Leserman J, Keefe FJ, Hu YJ, Toomey TC. Effects of coping on health outcome among female patients with gastrointestinal disorders. Psychosom Med 2000; 62:309-317.
2. Drossman DA, Creed FH, Olden KW, Svedlund J, Toner BB, Whitehead WE. Psychosocial aspects of the functional gastrointestinal disorders. Gut 1999; 45:II25-II30.
3. Levenstein S. Embracing complexity: what determines quality of life in inflammatory bowel disease? Eur J Gastroenterol Hepatol 2004; 16:1253-1255.
4. Drossman DA. Presidential address: gastrointestinal illness and biopsychosocial model. Psychosom Med 1998; 60:258-267.
5. Walker EA, Gelfand AN, Gelfand MD, Katon WJ. Psychiatric diagnoses, sexual and physical victimization, and disability in patients with irritable bowel syndrome or inflammatory bowel disease. Psychol Med 1995; 25:1259-1267.
6. Drossman DA, Creed FH, Olden KW, Svedlund J, Toner BB, Whitehead WE. Psychosocial aspects of the functional gastrointestinal disorders. Gut 1999; 45:II25-II30.
7. Crohn BB, Ginzburg L, Oppenheimer GD. Regional ileitis. JAMA 1932; 99:1323-1329.
8. Alexander F. Psychosomatic Medicine. New York: Norton; 1950.
9. Mawdsley JE, Rampton DS. Psychological stress and IBD: New insights into pathogenic and therapeutic implications. Gut 2005; 54:1481-1491.
10. Pace F, Molteni P, Bollani S, et al. Inflammatory bowel disease versus irritable bowel syndrome: A hospital-based, case-control study of disease impact on quality of life. Scand J Gastroenterol 2003; 38:1031-1038.
11. Rao SS, Hatfield RA, Suls JM, Chamberlain MJ. Psychological and physical stress induce differential effects on human colonic motility. Am J Gastroenterol 1998; 93:985-990.
12. Maunder R. Mediators of stress effects in inflammatory bowel disease: not the usual suspects. J Psychosom Res 2000; 48:569-577.
13. Levenstein S, Prantera C, Varvo V, et al. Stress and exacerbation in ulcerative colitis: a prospective study of patients enrolled in remission. Am J Gastroenterol 2000; 95:1213-1220.
14. Jones MP, Wessinger S, Crowell MD. Coping strategies and interpersonal supports in patients with irritable bowel syndrome and inflammatory bowel disease. Clin Gastroenterol Hepatol 2006; 4:474-481.
15. Graff LA, Walker JR, Lix L, et al. The relationship of inflammatory bowel disease type and activity to psychological functioning and quality of life. Clin Gastroenterol Hepatol 2006; 4:1491-1501.
16. Casellas F, Lopez-Vivancos J, Badia X, Vilaseca J, Malagelada JR. Impact of surgery for Crohn's disease on health-related quality of life. Am J Gastroenterol 2000; 95:177-182.
17. Tang LYL, Nabalamba A, Graff LA, Bernstein CN: A comparison of self-perceived health status in inflammatory bowel disease and irritable bowel syndrome patients from a Canadian national population survey. Can J Gastroenterol 2008; 22:475-483.
18. Sperber AD, Carmel S, Atzmon Y, et al. The Functional Bowel Disorder Severity Index (FBDSI) in a study of patients with the irritable bowel syndrome and fibromyalgia. Am J Gastroenterol 2000; 95:995-998.
19. Whitehead WE, Palsson O, Jones KR. Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications? Gastroenterology 2002; 122:1140-1156.
20. Creed F. The relationship between psychosocial parameters and outcome in irritable bowel syndrome. Am J Med 1999; 107:74S-80S.
21. Guthrie E, Jackson J, Shaffer J, et al. Psychological disorder and severity of inflammatory bowel disease predict health-related quality of life in ulcerative colitis and Crohn's disease. Am J Gastroenterol. 2002; 97:1994-1999.
22. Bernklev T, Jahnsen J, Aadland E, et al, and the IBSEN Study Group. Health-related quality of life in patients with inflammatory bowel disease five years after the initial diagnosis. Scand J Gastroenterol 2004; 39:365-373.
23. Drossman DA, Corazziari E, Talley NJ, Thompson WG, Whitehead WE. Rome II. The Functional Gastrointestinal Disorders. Diagnosis, Pathophysiology and Treatment: A Multinational Consensus. 2nd ed. McLean, Va: Degnon Associates; 2000:1-764.
24. Creed FH, Ratcliffe J, Fernandes L, et al. Depressive, panic and neurasthenic disorders predict poor outcome in severe irritable bowel syndrome unless suitably treated. Br J Psychiatry 2005; 186:507-515.
25. Halder SL, Locke GR III, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ III. Impact of functional gastrointestinal disorders on health-related quality of life: a population-based case-control study. Aliment Pharmacol Ther 2004; 19:233-242.
26. Quartero AO, Post MW, Numans ME, de Melker RA, de Wit NJ. What makes the dyspeptic patient feel ill? A cross sectional survey of functional health status, Helicobacter pylori infection, and psychological distress in dyspeptic patients in general practice. Gut 1999; 45:15-19.
27. Badia X, Mearin F, Balboa A, et al. Burden of illness in irritable bowel syndrome comparing Rome I and Rome II criteria. Pharmacoeconomics 2002; 20:749-758.
28. Drossman DA, Li Z, Leserman J, Toomey TC, Hu Y. Health status by gastrointestinal diagnosis and abuse history. Gastroenterology 1996; 110:999-1007.
29. Talley NJ, Fett SL, Zinsmeister AR. Self-reported abuse and gastrointestinal disease in outpatients: association with irritable boweltype symptoms. Am J Gastroenterol 1995; 90:366-371.
30. Johnson CF. Child sexual abuse. Lancet 2004; 364:462-470.
31. Laws A. Sexual abuse history and women's medical problems. J Gen Intern Med 1993; 8:441-443.
32. Dimenas E, Glise H, Hallerback B, Hernqvist H, Svedlund J, Wiklund I. Well-being and gastrointestinal symptoms among patients referred to endoscopy owing to suspected duodenal ulcer. Scand J Gastroenterol 1995; 30:1046-1052.
33. Biggs AM, Aziz Q, Tomenson B, Creed F. Do childhood adversity and recent social stress predict health care use in patients presenting with upper abdominal or chest pain? Psychosom Med 2003; 65:1020-1028.
34. Heaton KW. What makes people with abdominal pain consult their doctor. In: Creed FH, Mayou R, Hopkins A, eds. Medical Symptoms Not Explained by Organic Disease. London: Royal Colleges of Physicians and Psychiatrists; 1992:1-8.
35. Guthrie EA, Creed FH, Whorwell PJ, Tomenson B. Outpatients with irritable bowel syndrome: a comparison of first time and chronic attenders. Gut 1992; 33:361-363.
36. Lydiard RB, Greenwald S, Weissman MM, Johnson J, Drossman DA, Ballenger JC. Panic disorder and gastrointestinal symptoms: findings from the NIMH Epidemiologic Catchment Area project. Am J Psychiatry 1994; 151:64-70.
37. Creed F, Morgan R, Fiddler M, Marshall S, Guthrie E, House A. Depression and anxiety impair health-related quality of life and are associated with increased costs in general medical inpatients. Psychosomatics 2002; 43:302-309.
38. Acosta-Ramirez D, Pagan-Ocasio V, Torres EA, Rodriguez M, Caro O. Profile of the inflammatory bowel disease patient with depressive disorders. Puerto Rico Health Sci J 2001; 20:215-220.
39. Craig TKJ. Abdominal pain. In: Brown GW, Harris TO, eds. Life Events and Illness. New York, NY: Guilford; 1989:233-259.
40. Porcelli P, Leoci C, Guerra V. A prospective study of the relationship between disease activity and psychologic distress in patients with inflammatory bowel disease. Scand J Gastroenterol 1996; 31:792-796.
41. Mittermaier CC, Dejaco C, Waldhoer T, et al. Impact of depressive mood on relapse in patients with inflammatory bowel disease: a prospective 18-month follow-up study. Psychosom Med 2004; 66:79-84.
42. Simren M, Axelsson J, Gillberg R, et al. Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors. Am J Gastroenterol 2002; 97:389-396.
43. Walker EA, Katon WJ. Researching the health effects of victimization: the next generation. Psychosom Med 1996; 58:16-17.
44. North CS, Alpers DH, Helzer JE, Spitznagel EL, Clouse RE. Do life events or depression exacerbate inflammatory bowel disease? Ann Intern Med 1991; 114:381-386.
45. Kurina LM, Goldacre MJ, Yeates D, Gill LE. Depression and anxiety in people with inflammatory bowel disease. J Epidemiol Community Health 2001; 55:716-720.
46. Boye B, Jahnsen J, Mokleby K, Leganger S, Jantschek G, Jantschek I, Kunzendorf S, Benninghoven D, Wilhelmsen I, Sharpe M, Blomhoff S, Malt UF, Lundin KE. The INSPIRE study: are different personality traits related to disease-specific quality of life (IBS - Q) in distressed patients with ulcerative colitis and Crohn's disease? Inflamm Bowel Dis 2008; 14(5):680-686.
47. Gerbert B. Psychological aspects of Crohn's disease. J Behav Med 1980; 3:41-58.
48. Raja SN, Williams S, McGee R. Multidimensional health locus of control beliefs and psychological health for a sample of mothers. Soc Sci Med 1994; 39:213-220.
49. Ondersma SJ, Lumley MA, Corlis ME, et al. Adolescents with inflammatory bowel disease: the roles of negative affectivity and hostility in subjective versus objective health. J Pediatr Psychol 1997; 22:723-738.
50. Von Wietersheim JV, Kessler H: Psychotherapy with Chronic Inflammatory Bowel Disease Patients: A Review. Inflamm Bowel Dis 2006; 12:1175-1184.
51. O'Connor JF, Daniels G, Flood C, et al. An evaluation of the effectiveness of psychotherapy in the treatment of ulcerative colitis. Ann Int Med 1964; 60:587-602.
52. Künsebeck HW, Lempa W, Freyberger H. Kurz - und Langzeiteffekte ergänzender Psychotherapie bei Morbus Crohn. In: Lamprecht F, ed. Spezialisierung und Integration in Psychosomatik und Psychotherapie. Berlin: Springer; 1987:253-262.
53. Jantschek G, Zeitz M, Pritsch M, et al. Effect of psychotherapy on the course of Crohn's disease. Results of the German prospective multicenter psychotherapy treatment study on Crohn's disease. Scand J Gastroenterol 1998; 33:1289-1296.
54. Maunder RG, Esplen MJ. Supportive-expressive group psychotherapy for persons with inflammatory bowel disease. Can J Psychiatry.2001; 46:622-626.
55. Drossman DA, Toner BB, Whitehead WE, Diamant NE, Dalton CB, Duncan S, Emmott S, Proffitt V, Akman D, Frusciante K, Le T, Meyer K, Bradshaw B, Mikula K, Morris CB, Blackman CJ, Hu Y, Jia H, Li JZ, Koch GG, Bangdiwala SI. Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders. Gastroenterology 2003; 125:19-31.[PubMed: 12851867]
56. Boyce P, Talley N, Balaam B, et al. A randomized controlled trial of cognitive behavior therapy, relaxation training and routine clinical care for the irritable bowel syndrome. Am J Gastroenterol 2003; 98(10):2209-2218.
57. Levy RL, Olden KW, Naliboff BD, Bradley LA, Francisconi C, Drossman DA, Creed F. Psychosocial aspects of the functional gastrointestinal disorders. Gastroenterology 2006; 130:1447-1458.[PubMed:16678558]
58. Department of Health. Treatment Choice in Psychological Therapies and Counseling: Evidence Based Clinical Guidelines. UK Department of Health; 2001.
59. Lackner JM, Jaccard J, Krasner SS, Katz LA, Gudleski GD, Blanchard EB. How does cognitive behavior therapy for irritable bowel syndrome work? A mediational analysis of a randomized clinical trial. Gastroenterology 2007; 133:433-444. [PubMed: 17681164]
60. Lackner JM, Jaccard J, Krasner SS, Katz LA, Gudleski GD, and Holroyd K: Self administered cognitive behavior therapy for moderate to severe IBS: Clinical efficacy, tolerability, feasibility. Clin Gastroenterol Hepatol. 2008 August; 6(8): 899-906. doi:10.1016/j.cgh.2008.03.004.
61. Whitehead W, Palsson O. Is rectal pain sensitivity a biological marker for irritable bowel syndrome: psychological influences on pain perception. Gastroenterology 1998; 115:1263-1271.
62. Gibbs-Gallagher N, Palsson OS, Levy RL, et al. Selective recall of gastrointestinal-sensation words: evidence for a cognitive behavioral contribution to irritable bowel syndrome. Am J Gastroenterol 2001; 96(4):1133-1138.
63. Boyce P, Gilchrist J, Talley N. et al. Cognitive-behaviour therapy as a treatment for irritable bowel syndrome: a pilot study. Aust N Z J Psychiatry 2000; 34:300-309.
64. Greene B, Blanchard EB. Cognitive therapy for irritable bowel syndrome. J Consult Clin Psychol 1994; 62(3):576-582.
65. Vollmer A, Blanchard EB. Controlled comparison of individual versus group cognitive therapy for irritable bowel syndrome. Behav Ther 1998; 29(1):19-33.
66. Payne A, Blanchard EB. A controlled comparison of cognitive therapy and self-help support groups in the treatment of irritable bowel syndrome. J Consult Clin Psychol 1995; 63(5):779-786.
67. Garcia-Vega E, Fernandez-Rodriguez C. A stress management programme for Crohn's disease. Behav Res Ther 2004; 42:367-383.
68. Shepanski MA, Hurd LB, Culton K, et al. Health-related quality of life improves in children and adolescents with inflammatory bowel disease after attending a camp sponsored by the Crohn's and Colitis Foundation of America. Inflamm Bowel Dis 2005; 11:164-170.
69. Kennedy AP, Nelsen E, Reeves D, et al, and the North-West Regional Gastrointestinal Research Group. A randomized controlled trial to assess the effectiveness and cost of a patient orienteated self management approach to chronic inflammatory bowel disease. Gut 2004; 53:1639-1645.
70. Elsenbruch S, Langhorst J, Popkirowa K, et al. Effects of mindbody therapy on quality of life and neuroendocrine and cellular immune functions in patients with ulcerative colitis. Psychother Psychosom 2005; 74:277-287.
71. Van Dulmen A, Fennis J, Bleijenberg G. Cognitive-behavioral group therapy for irritable bowel syndrome: effects and longterm followup. Psychosom Med 1996; 58(5):508-514.
72. Milne B, Joachim G, Niedhardt J. A stress management program for inflammatory bowel disease patients. J Adv Nurs 1986; 11:561-567.
73. Mussell M, Bocker U, Nagel N. Reducing psychological distress in patients with inflammatory bowel disease by cognitive-behavioural treatment: exploratory study of effectiveness. Scand J Gastroenterol 2003; 38:755-762.
74. Waters BM, Jensen L, Fedorak RN. Effects of formal education for patients with inflammatory bowel disease: a randomized controlled trial. Can J Gastroenterol 2005; 19:235-244.
75. Schwarz SP, Blanchard EB. Evaluation of a psychological treatment for inflammatory bowel disease. Behav Res Ther 1991; 29:167-177.
76. Larsson KM, Sundberg Hjelm M, Karlbom U, et al. A group-based patient education programme for high-anxiety patients with Crohn disease or ulcerative colitis. Scand J Gastroenterol 2003; 38:763-769.
77. Miehsler W, Weichselberger M, Offerlbauer E, et al. Assessing the demand for psychological care in chronic diseases: development and validation of a questionnaire based on the example of inflammatory bowel disease. Inflamm Bowel Dis 2004; 10:637-645.
78. Caprilli R, Gassuli MA, Escher JC, et al. European evidence based consensus on the diagnosis and management of Crohn's disease: special situations. Gut 2006; 55:36-58.
79. Blanchard, EB. Irritable bowel syndrome: Psychosocial assessment and treatment. APA; 2001.
80. Kazdin AE. Progression of Therapy Research and Clinical Application of Treatment Require Better Understanding of the Change Process. Clin Psychol 2001; 8:143-151.
81. Drossman, DA. Chang, L. Psychosocial factors in the care of patients with GI disorders. In: Yamada, T., editor. Textbook of Gastroenterology. Lippincott-Raven; Philadelphia: 2002. p. 636-654.
82. Price JR, Couper J. Cognitive behaviour therapy for adults with chronic fatigue syndrome. Cochrane Review, latest version: August 1998. In: The Cochrane Library. Oxford, England.
83. Surawy C, Hackmann A, Hawton K, et al. Chronic fatigue syndrome: a cognitive approach. Behav Res Ther 1995; 33(5):535-544.